quinacrine has been researched along with Eye Abnormalities in 1 studies
Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
quinacrine : A member of the class of acridines that is acridine substituted by a chloro group at position 6, a methoxy group at position 2 and a [5-(diethylamino)pentan-2-yl]nitrilo group at position 9.
Eye Abnormalities: Congenital absence of or defects in structures of the eye; may also be hereditary.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hunter, AG | 1 |
| Ray, M | 1 |
| Langston, C | 1 |
1 other study available for quinacrine and Eye Abnormalities
| Article | Year |
|---|---|
Cebocephaly in an infant with trisomy 18.
Topics: Brain; Chromosomes, Human; Chromosomes, Human, 16-18; Cytological Techniques; Eye Abnormalities; Gen | 1977 |